Optimizing Precision Medicine in Gastric Cancer Care: Essential Guidance on Translating Scientific Advances with Novel HER2-Targeted Therapies and Other Agents into Current Clinical Practice

1.00 hr(s) | CME , MOC , ABIM

Specialty: Gastric Cancer

Therapeutic Area(s): Oncology

Release Date: July 21, 2020

Expiration Date: July 20, 2021

Location: Internet Activity Enduring

In this new CME/MOC-accredited video activity, Josep Tabernero, MD, PhD; Geoffrey Ku, MD; and Kohei Shitara, MD, synthesize the latest data of emerging and available novel therapies and consider the future of gastric cancer care. These experts also examine best practices for testing biomarkers such as HER2, PD-L1, and MSI, and provide guidance on integrating scientific advances and novel therapeutics into sound, evidence-based management strategies to improve outcomes for patients with gastric cancer.

Access this activity
Share via
Copy link
Powered by Social Snap